Ja Morgan

Ja Morgan

Harvard University - Cambridge / United States
Others
AD Scientific Index ID: 1343827
person_outline Ja Morgan's MOST POPULAR ARTICLES
1-) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trialGD Demetri, AT van Oosterom, CR Garrett, ME Blackstein, MH Shah, ...The Lancet 368 (9544), 1329-1338, 200629482006
2-) Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibTF Chu, MA Rupnick, R Kerkela, SM Dallabrida, D Zurakowski, L Nguyen, ...The Lancet 370 (9604), 2011-2019, 200711292007
3-) Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitorsCP Raut, M Posner, J Desai, JA Morgan, S George, D Zahrieh, ...Journal of Clinical Oncology 24 (15), 2325-2331, 20065472006
4-) Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumorsJ Desai, L Yassa, E Marqusee, S George, MC Frates, MH Chen, ...Annals of internal medicine 145 (9), 660-664, 20064792006
5-) Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumorsAJ Wagner, I Malinowska-Kolodziej, JA Morgan, W Qin, CDM Fletcher, ...Journal of clinical oncology 28 (5), 835-840, 20104612010